TITLE

Nitric oxide

AUTHOR(S)
Young, Duncan
PUB. DATE
December 2002
SOURCE
Continuing Education in Anaesthesia, Critical Care & Pain;Dec2002, Vol. 2 Issue 6, p161
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This article discusses the use of nitric oxide in the treatment of diseases. It explains the ability of inhaled nitric oxide to reduce the use of extra-corporeal membrane oxygenation (ECMO) in neonates with pulmonary hypertension. It also notes the effectiveness of inhaled nitric oxide in improving the condition of adults with type 1 respiratory failure. The article also reminds about the failure of nitric oxide in the treatment of septic shock.
ACCESSION #
44397952

 

Related Articles

  • Nitric Oxide Administration Using an Oxygen Hood: A Pilot Trial. Ambalavanan, Namasivayam; El-Ferzli, George T.; Roane, Claire; Johnson, Robert; Carlo, Waldemar A. // PLoS Clinical Trials;Feb2009, Vol. 6 Issue 2, Special section p1 

    Background: We have shown earlier that inhaled nitric oxide (iNO) administered by oxygen hood reduces pulmonary hypertension in an animal model (J Perinatol 2002; 22:50-6). Our objective in this study was to determine feasibility of iNO by oxygen hood in neonates with elevated alveolar-arterial...

  • Clinical perspectives with long-term pulsed inhaled nitric oxide for the treatment of pulmonary arterial hypertension. Barst, Robyn J.; Channick, Richard; Ivy, Dunbar; Goldstein, Brahm // Pulmonary Circulation;2012, Vol. 2 Issue 2, p139 

    Pulmonary arterial hypertension (PAH) is a chronic, progressive disease of the pulmonary vasculature with a high morbidity and mortality. Its pathobiology involves at least three interacting pathways - prostacyclin (PGI2), endothelin, and nitric oxide (NO). Current treatments target these three...

  • NITRIC OXIDE, (NO): A CLINICAL PRIMER. Wheeler, David // Focus Journal;Fall2012, p14 

    The article offers information on the molecule nitric oxide (NO). NO is a vasodilator used in the treatment of persistent pulmonary hypertension of the newborn (PPHN). A clinical effect of the use of NO is the enhanced oxygenation in acute lung injury (ALI) and acute respiratory distress...

  • Neonatal pulmonary hypertension treated with inhaled nitric oxide and high-frequency ventilation. Coates, E. W.; Klinepeter, M. E.; O'Shea, T. M. // Journal of Perinatology;Oct2008, Vol. 28 Issue 10, p675 

    Term and near-term infants with pulmonary hypertension are frequently treated with inhaled nitric oxide. This therapy can be delivered with high-frequency ventilation, but there has been limited study of the relative effectiveness of high-frequency jet ventilation and high-frequency oscillatory...

  • Nitric Oxide and Septic Shock.  // BioWorld Today;12/21/2009, Vol. 20 Issue 244, Special section p2 

    The article discusses research on the possible use of nitric oxide as treatment for septic shock. It references a 2009 study conducted by scientists at the research institute VIB and Ghent University in Belgium, published in the "Journal of Experimental Medicine." It cites that the research...

  • 732 Responsiveness to inhaled nitric oxide in patients with pulmonary arterial hypertension and right heart failure. Podolec, P.; Kaznica-Wiatr, M.; Hlawaty, M.; Wilkolek, P.; Podolec, Z.; Kopec, G.; Tracz, W. // European Journal of Heart Failure. Supplements;Jun2006, Vol. 5 Issue 1, p171 

    An abstract of the study "Responsiveness to Inhaled Nitric Oxide in Patients With Pulmonary Arterial Hypertension and Right Heart Failure," by P. Podolec et al. is presented.

  • Treatment of pulmonary hypertension with inhaled nitric oxide during hepatic transplantation in... Tarquino, Mario; Geggel, Robert L.; Strauss, Richard S.; Rhodes, Jonathan; Wunderlich, Bebe; Rohrer, Richard J. // Clinical Pediatrics;Aug1998, Vol. 37 Issue 8, p505 

    Describes the effect of inhaled nitric oxide in the perioperative management of pulmonary hypertension in an adolescent undergoing liver transplantation. Partial reversibility of pulmonary hypertension six months after transplantation; Patient characteristics; Prevalence of pulmonary...

  • Citrobacter Sepsis and Severe Newborn Respiratory Failure Supported With Extracorporeal Membrane Oxygenation. Rais-Bahrami, Khodayar; Short, Billie L // Journal of Perinatology;Jun2000, Vol. 20 Issue 4, p265 

    An infant with fulminant Citrobacter sepsis and respiratory failure is presented. The severity of respiratory failure and the need for systemic heparinization on extracorporeal membrane oxygenation delayed the opportunity of initial lumbar puncture to rule out meningitis. The infant was...

  • A Randomized Trial of Nasopharyngeal-Synchronized Intermittent Mandatory Ventilation Versus Nasopharyngeal Continuous Positive Airway Pressure in Very Low Birth Weight Infants After Extubation. Friedlich, Philippe; Lecart, Chantal; Posen, Robert; Ramicone, Emily; Chan, Linda; Ramanathan, Rangasamy // Journal of Perinatology;Sep99, Vol. 19 Issue 6, p413 

    OBJECTIVE: To prospectively compare the incidence of respiratory failure in premature infants randomized to receive either nasopharyngeal continuous positive airway pressure (NPCPAP) or nasopharyngeal-synchronized intermittent mandatory ventilation (NP-SIMV) in the immediate postextubation...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics